Hipertansiyonda Tanı ve Tedavi Yaklaşımları
Özet
Hipertansiyon, arteriyel kan basıncının sürekli yüksek seyretmesiyle karakterize, küresel ölçekte ciddi bir halk sağlığı sorunudur. Kardiyak hastalıkların en yaygın risk faktörü olan bu klinik durum; kontrol altına alınmadığında kalp yetmezliği, koroner arter ve renal hastalıklar gibi ağır sekonder komplikasyonlara yol açmaktadır. Patofizyolojik olarak primer ve sekonder olmak üzere ikiye ayrılan hastalığın gelişiminde; kalıtım, obezite, beslenme tarzı ve sempatik sinir sisteminin aşırı aktivitesi gibi çoklu faktörler rol oynamaktadır. Tanı sürecinde klinikte standartlara uygun ve iki koldan yapılan kan basıncı ölçümlerinin yanı sıra, beyaz önlük ile maskeli hipertansiyonun tespiti için ambulatuar ve evde takip yöntemleri kritik önem taşır. Tedavi yaklaşımı ise tamamen bireyselleştirilmiş olup bütüncül bir strateji gerektirir. Tuz kısıtlaması, kilo kontrolü ve hafif-orta yoğunluktaki kardiyovasküler egzersizleri içeren non-farmakolojik yaşam tarzı değişiklikleri temel basamağı oluşturur. Bu süreç; hastanın spesifik risk analizine göre seçilen ACE inhibitörleri, ARB'ler, kalsiyum kanal blokerleri, diüretikler veya beta blokerler gibi farmakolojik tedavilerle kombine edilerek mortalite ve morbidite oranlarını belirgin şekilde azaltmaktadır.
Hypertension is a critical global public health issue characterized by persistently elevated arterial blood pressure. As the most prevalent risk factor for cardiac diseases, this clinical condition leads to severe secondary complications such as heart failure, coronary artery disease, and renal disorders when left uncontrolled. Pathophysiologically classified into primary and secondary hypertension, its development involves multiple factors including heredity, obesity, dietary habits, and overactivity of the sympathetic nervous system. In the diagnostic process, alongside standard blood pressure measurements performed in the clinic from both arms, ambulatory and home monitoring methods hold vital importance for detecting white-coat and masked hypertension. The therapeutic approach is entirely individualized and requires a comprehensive strategy. Non-pharmacological lifestyle modifications, including sodium restriction, weight management, and light-to-moderate cardiovascular exercises, form the foundational step. This process significantly reduces mortality and morbidity rates when combined with pharmacological treatments, such as ACE inhibitors, ARBs, calcium channel blockers, diuretics, or beta-blockers, selected based on the specific risk analysis of the patient.
Referanslar
Woodwell DA, Chery DK, National Ambulatory Medical Care Survey;2002 summary.Adv data 2004;26;1-44.
Moxey ED, O’Connor JP, Novielli KD, Teutsch S, Nash DB. Prescription drug use in the elderly: a descriptive analysis. Health Care Financ Rev. 2003;24:127–141.
Egan BM, et al.Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008. Circulation.2011:124(9):1046-58.
Ihab Hajjar, MD, MS; Theodore A. Kotchen, MD;Trends in Prevalence, Awareness, Treatment, and Control of Hypertension in the United States, 1988-2000;JAMA. 2003;290(2):199-206. doi:10.1001/jama.290.2.199.
Youfa Wang, Qiong Joanna Wang, The Prevalence of Prehypertension and Hypertension Among US Adults According to the New Joint National Committee GuidelinesNew Challenges of the Old Problem, Arch Intern Med. 2004;164(19):2126-2134. doi:10.1001/archinte.164.19.2126.
Gareth Beevers, Gregory Y H Lip, Eoin O'Brien; The pathophysiology of hypertension; BMJ 2001;322:912.
John E. Hall,Joey P. Granger,Jussara M. do Carmo,Alexandre A. da Silva,John Dubinion,Eric George,Shereen Hamza,Joshua Speed,Michael E. Hall;Hypertension: Physiology and Pathophysiology; Comprehensive Physiology, Volume 2,Issue 4. October 2012.
Sinny Delacroix , Ramesh G Chokka, and Stephen G Worthley Hypertension: Pathophysiology and Treatment; J Neurol Neurophysiol 2014, 5:6.
The ACCORD Study Group,,Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus;N Engl J Med 2010; 362:1575-1585 DOI: 10.1056/NEJMoa1001286.
Omboni, Stefano, et al., Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study; Journal of Hypertension: November 2016 - Volume 34 - Issue 11 - p 2187-2198.
Pickering, TG.;The effects of environmental and lifestyle factors on blood pressure and the intermediary role of the sympathetic nervous system; Journal of Human Hypertension . Aug97 Supplement 1, Vol. 11, pS9-S18. 10p.
Neutel JM1, Smith DH;The circadian pattern of blood pressure: cardiovascular risk and therapeutic opportunities;Current Opinion in Nephrology and Hypertension, 01 May 1997, 6(3):250-256.
Roberto Sega, et al; Alterations of Cardiac Structure in Patients With Isolated Office, Ambulatory, or Home Hypertension; Circulation. 2001;104:1385–1392.
Kei Asayama, Takayoshi Ohkubo, Masahiro Kikuya, Hirohito Metoki, Haruhisa Hoshi, Junichiro Hashimoto, Kazuhito Totsune, Hiroshi Satoh and Yutaka ImaiPrediction of Stroke by Self-Measurement of Blood Pressure at Home Versus Casual Screening Blood Pressure Measurement in Relation to the Joint National Committee 7 Classification;Stroke. 2004;35:2356–2361.
Phyllis August,Initial Treatment of Hypertension; N Engl J Med 2003; 348:610-617.
S M Haffner,E Ferrannini,H P Hazuda andM P Stern;Clustering of cardiovascular risk factors in confirmed prehypertensive individuals.; Hypertension. 1992;20:38–45.
Labarthe Darwin, Carma Ayala;Nondrug intervetions in hypertension prevention and control; Cardiol clin; 2002;20;249-260.
Kawachi I1,Malcolm LA;The cost-effectiveness of treating mild-to-moderate hypertension: a reappraisal; Journal of Hypertension, 01 Mar 1991, 9(3):199-208.
James A. Blumenthal, PhD; Andrew Sherwood, PhD; Michael A. Babyak, PhD; et al; Effects of Exercise and Stress Management Training on Markers of Cardiovascular Risk in Patients With Ischemic Heart DiseaseA Randomized Controlled Trial; JAMA. 2005;293(13):1626-1634.
Patrıck r. Steffen, andrew sherwood, elızabeth c. D. Gullette, anastasıa georgıades, alan hınderlıter, and james a. Blumenthal ; Medicine & Science in Sports & Exercise2001;33;1635-1640, Effects of exercise and weight loss on blood pressure during daily life.
Tomoshige Hayashi et al;Walking to Work and the Risk for Hypertension in Men: The Osaka Health Survey;Annals of internal medicine1999:131;21-26.
Janet P. Wallace; Exercise in Hypertension; Sports Medicine volume 33, pages585–598 ;2003.
Paul R. Conlin, Dominic Chow, Edgar R. Miller, Laura P. Svetkey, Pao-Hwa Lin, David W. Harsha, Thomas J. Moore, Frank M. Sacks, Lawrence J. Appel ;The effect of dietary patterns on blood pressure control in hypertensive patients: Results from the dietary approaches to stop hypertension (DASH) trial; American Journal of Hypertension, Volume 13, Issue 9, September 2000, Pages 949–955.
Jamy D. Ard, Cynthia J. Coffman, Pao-Hwa Lin, Laura P. Svetkey ;One-year follow-up study of blood pressure and dietary patterns in dietary approaches to stop hypertension (DASH)–sodium participants; American Journal of Hypertension, Volume 17, Issue 12, December 2004, Pages 1156–1162.
George ABrayMDaWilliam MVollmerPhDbFrank MSacksMDcEvaObarzanekPhDdLaura PSvetkeyMDeLawrence JAppelMDf;A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium Trial;The American Journal of Cardiology Volume 94, Issue 2, 15 July 2004, Pages 222-227.
Ronald G. Victor, M.D.,and Jim Hansen, M.D.; Alcohol and Blood Pressure;N Engl J Med 1995; 332:1782-1783.
Influence of pattern of alcohol intake on blood pressure in regular drinkers a controlled trial Rakic, Valentina1,2; Puddey, Ian B.1; Burke, Valerie1; Dimmitt, Simon B.1; Beilin, Lawrence J.1;Influence of pattern of alcohol intake on blood pressure in regular drinkers a controlled trial; ournal of Hypertension: February 1998 - Volume 16 - Issue 2 - p 165-174.
Ramón Estruch,Emilio Sacanella,Alejandro De la Sierra,María Teresa Aguilera,Emília Antúnez,José M. Nicolás,Joaquín Fernández-Solá,Antonio Coca,Álvaro Urbano-Márquez; Effects of Alcohol Withdrawal on 24 Hour Ambulatory Blood Pressure Among Alcohol-Dependent Patients; Alcohol Clin Exp Res 2003:27;2002-2008.
Petrovitch H1, Vogt TM, KG Berge Search articles by 'K GBerge'BergeKG;Isolatedsystolichypertension: lowering the risk of stroke in older patients. SHEPCooperative Research Group;Geriatrics, 01Mar1992, 47(3):30-2, 35-8.
Staessen, Jan A; Wang, Ji-Guang; Thijs, Lutgarde;Cardiovascular prevention and blood pressure reductiona quantitative overview updated until 1 March 2003;Journal of Hypertension: June 2003 - Volume 21 - Issue 6 - p 1055-1076.
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial; Johannes FEMann et al ; L ancet 2008:372:547-553.
Krause T, et al; Management of hypertension: summary of NICE guidance; BMJ 2011; 343.
Kenneth Jamerson Et al; Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients; N Engl J Med 2008; 359:2417-2428.
Antihypertensive and Lipid-Lowering Treatment to Inhibitor or Calcium Channel Blocker vs Diuretic: The Randomized to Angiotensin-Converting Enzyme Major Outcomes in High-Risk Hypertensive Patients Prevent Heart Attack Trial (ALLHAT) ;JAMA. 2002;288(23):2981-2997 (doi:10.1001/jama.288.23.2981.
Jackson T. Et al; Outcomes in Hypertensive Black and Nonblack Patients Treated With Chlorthalidone, Amlodipine, and Lisinopril; JAMA. 2005;293(13):1595-1608.
John B.Kostis et al; Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes; The American Journal of Cardiology, Volume 95, Issue 1, 1 January 2005, Pages 53-54.
K.M. Chow at al; Risk factors for thiazide-induced hyponatraemia; An International Journal of Medicine, Volume 96, Issue 12, December 2003, Pages 911–917.
Wing, LMH, Reid CM, Ryan P, et al; A Comparison of Outcomes with Angiotensin-converting Enzyme Inhibitors and Diuretics for Hypertension in the Elderly; N Engl J Med 2003, 348:583–592.
Kamala P.TamirisaMDaKeith D.AaronsonMD, MSaTodd M.Koelling;Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure American Heart Journal
Kristian Wachtell, Mika Lehto, et al; Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study; J Am Coll Cardiol. 2005 Mar, 45 (5) 712–719.
Edoute, Yeouda; Nagachandran, Pradeep; Svirski, Boris; Ben-Ami, Haim;Cardiovascular Adverse Drug Reaction Associated with Combined β-Adrenergic and Calcium Entry-Blocking Agents; Journal of Cardiovascular Pharmacology: April 2000 - Volume 35 - Issue 4 - p 556-559.
Chris Jensen, Peter Herold & Hans Rudolf Brunner ;Aliskiren: the first renin inhibitor for clinical treatment; Nature Reviews Drug Discovery volume 7, pages399–410 2008.
John J.V. McMurray,Bertram Pitt,Et al;Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure; Circulation: Heart Failure. 2008;1:17–24.
Association Between Cardiovascular Outcomes and Antihypertensive Drug Treatment in Older Women;Sylvia Wassertheil-Smoller, PhD; Bruce Psaty, MD, PhD; Philip Greenland, MD; et al; JAMA. 2004;292(23):2849-2859. doi:10.1001/jama.292.23.2849.
Bruce M. Psaty, MD, PhD; Thomas Lumley, PhD; Curt D. Furberg, MD, PhD; et alHealth Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents;JAMA. 2003;289(19):2534-2544.
Joel M. Neutel, MichaelA. Weber, Stevo Julius, Jay N. Cohn, Prasad Turlapaty, Yannan Shen, Weinong Guo, Alicia Batchelor & Hjalmar Lagast Clinical Experience with Perindopril in Elderly Hypertensive Patients;American Journal of Cardiovascular Drugs volume 4, 335–341 2004.
Steven R. Erickson Pharm.D.,Brent C. Williams M.D., M.P.H.,Larry D. Gruppen Ph.D.Relationship Between Symptoms and Health-Related Quality of Life in Patients Treated for Hypertension;pharmacotherapy 2004:24;344-350.
Montán, Sven; Drugs used in hypertensive diseases in pregnancy; Current Opinion in Obstetrics and Gynecology: April 2004 - Volume 16 - Issue 2 - p 111-115)
Stevo Julius, Sverre E. Kjeldsen, Hans Brunner, Lennart Hansson, Francis Platt, Steffan Ekman, John H. Laragh, Gordon McInnes, Anthony M. Schork, Beverly Smith ... Show more;VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk; American Journal of Hypertension, Volume 16, Issue 7, July 2003, Pages 544–548.
Philip T.RodgersPharmD;Combination Drug Therapy in Hypertension: A Rational Approach for the Pharmacist;Journal of the American Pharmaceutical Association (1996)Volume 38, Issue 4, July–August 1998, Pages 469-479.
Ruilope, Luis Miguel de la Sierra, Alejandro2; Moreno, Emilio3; Fernández, Raúl3; Garrido, Jesus3; de la Figuera, Mariano4; de la Cámara, Agustín Gómez1; Coca, Antonio2; Luque-Otero, Manuel5 on behalf of the EDICTA Study Group, Spain;Prospective comparison of therapeutical attitudes in hypertensive type 2 diabetic patients uncontrolled on monotherapy.;Journal of Hypertension: December 1999 - Volume 17 - Issue 12 - p 1917-1923.
Anderson GH Jr ,Blakeman N DH Streeten Search articles by 'D H Streeten'Streeten DH;The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients; Journal of Hypertension, 01 May 1994, 12(5):609-615.
Inge H.H.T. Klein, Gerry Ligtenberg, Jutta Neumann, P. Liam Oey, Hein A. Koomans and Peter J. Blankestijn ;Sympathetic Nerve Activity Is Inappropriately Increased in Chronic Renal Disease; JASN December 2003, 14 (12) 3239-3244.
Zalunardo, Nadiaa; Tuttle, Katherine R;Atherosclerotic renal artery stenosis: current status and future directions; Current Opinion in Nephrology and Hypertension: November 2004 - Volume 13 - Issue 6 - p 613-621.
Rabbia, C; Valpreda, S;Duplex scan sonography of renal artery stenosis; International Angiology; Turin Vol. 22, Iss. 2, (Jun 2003): 101-15.
Jeffrey W Olin; Atherosclerotic renal artery dissease; cardiology clinics volüme ;20,ıssue 4;547-562,2002.
Veglio F1,Morello F,Rabbia F,Leotta G,P.Mulatero P ;Recent advances in diagnosis and treatment of primary aldosteronism; Minerva Medica, 01 Aug 2003, 94(4):259-265.Volume 148, Issue 6, December 2004, Pages 971-978.
G. Arnaldi, A. Angeli, A. B. Atkinson, X. Bertagna, F. Cavagnini, G. P. Chrousos, G. A. Fava, J. W. Findling, R. C. Gaillard, A. B. Grossman;Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement; The Journal of Clinical Endocrinology & Metabolism, Volume 88, Issue 12, 1 December 2003, Pages 5593–5602.
